Impact of the subcutaneous formulations of trastuzumab and rituximab on efficiency and resource optimization in Spanish hospitals: H-Excelencia study.

ABSTRACT:

Background

Subcutaneous (SC) versus intravenous (IV) administration is advantageous in terms of patient convenience and hospital efficiency. This study aimed to compare the effect of optimizing the processes involved in SC versus IV administration of rituximab and trastuzumab on hospital capacity and service quality.

Methods

This cross-sectional resource utilization study interviewed oncologists, hematologists, nurses, and pharmacists from 10 hospitals in Spain to estimate changes in processes associated with conversion from IV to SC rituximab and trastuzumab, based on clinical experience and healthcare use from administrative databases.

Results

Efficient use of SC formulations increased the monthly capacity for parenteral administration by 3.35% (potentially increasa

SUBMITTER: Abad-Sazatornil MR 

PROVIDER: S-EPMC8034176 | biostudies-literature | 2021 Apr

REPOSITORIES: biostudies-literature